News

Pictilisib plus fulvestrant boosts PFS in ER/PR+ patients

Publish date: December 10, 2014

 

AT SABCS 2014

References

msullivan@frontlinemedcom.com

Pages

Recommended Reading

Adjuvant ovarian suppression impairs QOL in women with breast cancer
MDedge ObGyn
VIDEO: SERMs move beyond osteoporosis, breast cancer prevention
MDedge ObGyn
None of 19 potential biomarkers predicted pertuzumab response
MDedge ObGyn
ROR score aids prognosis after 5 years on tamoxifen
MDedge ObGyn
Meditation, yoga earn high marks as supportive care during breast cancer treatment
MDedge ObGyn
VIDEO: An easy way to improve breast biopsy practices
MDedge ObGyn
Mastectomies, reconstruction, on the rise for women with early stage disease
MDedge ObGyn
Breast cancer relapse risk halved since 1986
MDedge ObGyn
Too many elderly with breast cancer still receive radiotherapy
MDedge ObGyn
Ultrasound screening for dense breasts is high cost, offers little benefit
MDedge ObGyn